Investors

Capital Cell is a venture capital fund that specializes in early-stage health tech and biotech investments, with check sizes ranging from $250k to $5M. The fund supports groundbreaking companies such as Ability Pharmaceuticals. Combining venture capital, business angels, and accredited investors, Capital Cell offers a unique equity crowdfunding platform for investing in non-listed companies. This approach enables global investors to support the future of medical science, providing detailed scientific and financial information on each project.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Recent Investments